Exostar Secure Access Manager (SAM) vs Ilex International IAM Platform: 2026 Comparison

Exostar Secure Access Manager (SAM)

Enterprise security teams managing clinical trial ecosystems should use Exostar Secure Access Manager for its purpose-built SSO across 122+ trial applications, eliminating the friction of federated identity management across sponsor and site networks. The platform's automated provisioning workflows combined with real-time audit trails and training compliance tracking directly address FDA and ICH regulatory requirements that generic IAM platforms treat as afterthoughts. Not the right fit for organizations needing broad identity governance across non-clinical workloads; this tool's strength is precisely its narrow specialization in trial access workflows.

Ilex International IAM Platform

SMBs and mid-market firms without dedicated IAM teams will find real value in Ilex International IAM Platform's passwordless authentication and user lifecycle automation, which cuts provisioning overhead that typically drains smaller security ops. The platform handles both employee and customer identity (CIAM included) across hybrid deployments, and its hybrid flexibility means you're not locked into cloud-only or on-premises thinking. Skip this if you need deep API-first architecture or heavy integration with Okta-centric ecosystems; Ilex's European roots and smaller vendor footprint mean fewer third-party connectors out of the box.